Cite
Acquired Epiblepharon Alleviated With Teprotumumab Treatment in Active Thyroid Eye Disease Patient
MLA
Paul O. Phelps, and Kevin W. Chen. “Acquired Epiblepharon Alleviated With Teprotumumab Treatment in Active Thyroid Eye Disease Patient.” Ophthalmic Plastic and Reconstructive Surgery, vol. 37, no. 6, July 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....61eb066b8f82e8e46231dd92ec9be5e1&authtype=sso&custid=ns315887.
APA
Paul O. Phelps, & Kevin W. Chen. (2021). Acquired Epiblepharon Alleviated With Teprotumumab Treatment in Active Thyroid Eye Disease Patient. Ophthalmic Plastic and Reconstructive Surgery, 37(6).
Chicago
Paul O. Phelps, and Kevin W. Chen. 2021. “Acquired Epiblepharon Alleviated With Teprotumumab Treatment in Active Thyroid Eye Disease Patient.” Ophthalmic Plastic and Reconstructive Surgery 37 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....61eb066b8f82e8e46231dd92ec9be5e1&authtype=sso&custid=ns315887.